vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Metallus Inc. (MTUS). Click either name above to swap in a different company.
Metallus Inc. is the larger business by last-quarter revenue ($267.3M vs $168.4M, roughly 1.6× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 11.1%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -8.8%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
ESPR vs MTUS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $267.3M |
| Net Profit | — | $-14.3M |
| Gross Margin | — | 2.2% |
| Operating Margin | 50.6% | -7.7% |
| Net Margin | — | -5.3% |
| Revenue YoY | 143.7% | 11.1% |
| Net Profit YoY | — | 33.2% |
| EPS (diluted) | $0.32 | $-0.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $267.3M | ||
| Q3 25 | $87.3M | $305.9M | ||
| Q2 25 | $82.4M | $304.6M | ||
| Q1 25 | $65.0M | $280.5M | ||
| Q4 24 | $69.1M | $240.5M | ||
| Q3 24 | $51.6M | $227.2M | ||
| Q2 24 | $73.8M | $294.7M | ||
| Q1 24 | $137.7M | $321.6M |
| Q4 25 | — | $-14.3M | ||
| Q3 25 | $-31.3M | $8.1M | ||
| Q2 25 | $-12.7M | $3.7M | ||
| Q1 25 | $-40.5M | $1.3M | ||
| Q4 24 | — | $-21.4M | ||
| Q3 24 | $-29.5M | $-5.9M | ||
| Q2 24 | $-61.9M | $4.6M | ||
| Q1 24 | $61.0M | $24.0M |
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 11.4% | ||
| Q2 25 | — | 10.6% | ||
| Q1 25 | — | 7.8% | ||
| Q4 24 | — | 4.5% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 15.7% |
| Q4 25 | 50.6% | -7.7% | ||
| Q3 25 | -11.4% | 3.6% | ||
| Q2 25 | 8.6% | 2.8% | ||
| Q1 25 | -34.0% | 1.0% | ||
| Q4 24 | -6.4% | -10.1% | ||
| Q3 24 | -31.0% | -3.1% | ||
| Q2 24 | 3.5% | 2.1% | ||
| Q1 24 | 52.5% | 9.3% |
| Q4 25 | — | -5.3% | ||
| Q3 25 | -35.9% | 2.6% | ||
| Q2 25 | -15.4% | 1.2% | ||
| Q1 25 | -62.2% | 0.5% | ||
| Q4 24 | — | -8.9% | ||
| Q3 24 | -57.2% | -2.6% | ||
| Q2 24 | -83.9% | 1.6% | ||
| Q1 24 | 44.3% | 7.5% |
| Q4 25 | $0.32 | $-0.34 | ||
| Q3 25 | $-0.16 | $0.19 | ||
| Q2 25 | $-0.06 | $0.09 | ||
| Q1 25 | $-0.21 | $0.03 | ||
| Q4 24 | $-0.14 | $-0.46 | ||
| Q3 24 | $-0.15 | $-0.13 | ||
| Q2 24 | $-0.33 | $0.10 | ||
| Q1 24 | $0.34 | $0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $156.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $686.0M |
| Total Assets | $465.9M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $156.7M | ||
| Q3 25 | $92.4M | $191.5M | ||
| Q2 25 | $86.1M | $190.8M | ||
| Q1 25 | $114.6M | $180.3M | ||
| Q4 24 | $144.8M | $240.7M | ||
| Q3 24 | $144.7M | $254.6M | ||
| Q2 24 | $189.3M | $272.8M | ||
| Q1 24 | $226.6M | $278.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $5.4M | ||
| Q3 24 | — | $13.2M | ||
| Q2 24 | — | $13.2M | ||
| Q1 24 | — | $13.2M |
| Q4 25 | $-302.0M | $686.0M | ||
| Q3 25 | $-451.4M | $697.7M | ||
| Q2 25 | $-433.5M | $690.0M | ||
| Q1 25 | $-426.2M | $686.1M | ||
| Q4 24 | $-388.7M | $690.5M | ||
| Q3 24 | $-370.2M | $712.7M | ||
| Q2 24 | $-344.2M | $736.3M | ||
| Q1 24 | $-294.3M | $739.3M |
| Q4 25 | $465.9M | $1.1B | ||
| Q3 25 | $364.0M | $1.2B | ||
| Q2 25 | $347.1M | $1.1B | ||
| Q1 25 | $324.0M | $1.1B | ||
| Q4 24 | $343.8M | $1.1B | ||
| Q3 24 | $314.1M | $1.1B | ||
| Q2 24 | $352.3M | $1.1B | ||
| Q1 24 | $373.1M | $1.2B |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.02× | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $-1.9M |
| Free Cash FlowOCF − Capex | — | $-37.2M |
| FCF MarginFCF / Revenue | — | -13.9% |
| Capex IntensityCapex / Revenue | 0.0% | 13.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-93.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $-1.9M | ||
| Q3 25 | $-4.3M | $22.0M | ||
| Q2 25 | $-31.4M | $34.8M | ||
| Q1 25 | $-22.6M | $-38.9M | ||
| Q4 24 | $-35.0M | $13.9M | ||
| Q3 24 | $-35.3M | $-15.3M | ||
| Q2 24 | $-7.2M | $8.3M | ||
| Q1 24 | $53.8M | $33.4M |
| Q4 25 | — | $-37.2M | ||
| Q3 25 | — | $-6.4M | ||
| Q2 25 | — | $17.0M | ||
| Q1 25 | — | $-66.4M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | $-35.5M | $-32.9M | ||
| Q2 24 | $-7.3M | $-5.8M | ||
| Q1 24 | $53.8M | $16.0M |
| Q4 25 | — | -13.9% | ||
| Q3 25 | — | -2.1% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | -23.7% | ||
| Q4 24 | — | -0.5% | ||
| Q3 24 | -68.7% | -14.5% | ||
| Q2 24 | -9.9% | -2.0% | ||
| Q1 24 | 39.0% | 5.0% |
| Q4 25 | 0.0% | 13.2% | ||
| Q3 25 | 0.0% | 9.3% | ||
| Q2 25 | 0.0% | 5.8% | ||
| Q1 25 | 0.0% | 9.8% | ||
| Q4 24 | 0.0% | 6.3% | ||
| Q3 24 | 0.3% | 7.7% | ||
| Q2 24 | 0.1% | 4.8% | ||
| Q1 24 | 0.1% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.72× | ||
| Q2 25 | — | 9.41× | ||
| Q1 25 | — | -29.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.80× | ||
| Q1 24 | 0.88× | 1.39× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
MTUS
| Industrial Market Sector | $95.3M | 36% |
| Manufactured Components | $67.8M | 25% |
| Aerospace And Defense | $39.6M | 15% |
| Seamless Mechanical Tubing | $31.3M | 12% |
| Energy Market Sector | $18.3M | 7% |
| Other | $11.3M | 4% |
| Other Market Sector | $3.7M | 1% |
